微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 9.2% | 2% | 48.39% | 27/159 | 1.2% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | 6.2% | -0.48% | 105.3% | 26/159 | 0.26% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | 3.02% | 7.09% | -54.03% | 31/159 | -0.37% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | 6.57% | -42.22% | -27.16% | 49/159 | -9.52% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 9.02% | -18.81% | 44.78% | 31/159 | 4.23% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 6.23% | -8.38% | 120.92% | 26/159 | 2.66% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 2.82% | -34.72% | -75.2% | 39/159 | 2.32% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 11.37% | 3.46% | 2.34% | 26/159 | -1.03% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 11.11% | -29.86% | 63.38% | 20/159 | 2.34% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 6.8% | 10.57% | 57.41% | 20/159 | 1.46% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 4.32% | -36.66% | -60.69% | 14/159 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 10.99% | 32.09% | -30.62% | 40/159 | 0.67% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 15.84% | 75.61% | 157.56% | 6/159 | 2.8% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 6.15% | 17.59% | -9.82% | 34/159 | 2.16% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 6.82% | 162.31% | -18.03% | 1/159 | 1.57% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 8.32% | 28.79% | -7.76% | 53/159 | 0.75% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 9.02% | 46.43% | 72.47% | 41/159 | 4.43% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 5.23% | 39.84% | 101.15% | 52/159 | 2.94% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 2.6% | 106.35% | -59.75% | 51/159 | 2.49% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 6.46% | 33.2% | 4.87% | 76/159 | 3.58% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 6.16% | -0.32% | 64.71% | 64/159 | 3.03% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 3.74% | 44.96% | 196.83% | 66/159 | 4.19% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 1.26% | -25.44% | -74.02% | 63/159 | 2.19% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 4.85% | 117.98% | -21.52% | 85/159 | 2.53% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 6.18% | 45.75% | 139.53% | 56/159 | 7.48% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 2.58% | 67.53% | 52.66% | 76/159 | 4.96% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 1.69% | 26.12% | 106.26% | 62/159 | 2.41% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | -26.98% | -742.38% | -736.32% | 130/159 | 6.99% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 4.24% | -78.56% | 175.32% | 77/159 | 7.18% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 1.54% | -58.38% | 14.93% | 90/159 | 4.6% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 1.34% | -25.56% | -68.1% | 70/159 | 2.54% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 4.2% | -30.69% | -78.77% | 89/159 | 9.61% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 19.78% | 158.56% | 434.59% | 6/159 | 8.29% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 3.7% | 32.14% | 105.56% | 64/159 | 5.58% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 1.8% | -4.26% | -70.3% | 47/159 | 2.09% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 6.06% | -25.55% | -20.78% | 74/159 | 6.19% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 7.65% | 15.38% | 173.21% | 37/159 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 2.8% | -39.78% | 48.94% | 56/159 | 3.48% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 1.88% | 10.59% | -76.9% | 42/159 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | 8.14% | -13.68% | 22.78% | 55/159 | 11.27% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | 6.63% | -8.93% | 42.58% | 40/159 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | 4.65% | -4.71% | 173.53% | 38/159 | 4.87% | 华东医药 | 36.97% | 行业排名> |
| 2015-03-31 | 1.7% | -19.43% | -81.97% | 44/159 | 2.41% | 华东医药 | 26.63% | 行业排名> |